Stephens RW - Search Results

1

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.

Kos J, Nielsen HJ, Krasovec M, Christensen IJ, Cimerman N, Stephens RW, Brünner N. Kos J, et al. Among authors: stephens rw. Clin Cancer Res. 1998 Jun;4(6):1511-6. Clin Cancer Res. 1998. PMID: 9626470

2

High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.

Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brünner N. Holten-Andersen MN, et al. Among authors: stephens rw. Clin Cancer Res. 2000 Nov;6(11):4292-9. Clin Cancer Res. 2000. PMID: 11106246

3

The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.

Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, Frigerio L, Ferrari A, Danø K, Brünner N, Blasi F. Sier CF, et al. Cancer Res. 1998 May 1;58(9):1843-9. Cancer Res. 1998. PMID: 9581823

4

Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.

Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sørensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brünner N. Holten-Andersen MN, et al. Among authors: stephens rw. Clin Cancer Res. 2002 Jan;8(1):156-64. Clin Cancer Res. 2002. PMID: 11801553

5

Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.

Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, Han C, Høyer-Hansen G, Smith K, Brünner N, Harris AL. Riisbro R, et al. Among authors: stephens rw. Clin Cancer Res. 2002 May;8(5):1132-41. Clin Cancer Res. 2002. PMID: 12006529

6

Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA.

Høgdall CK, Christensen IJ, Stephens RW, Sørensen S, Nørgaard-Pedersen B, Nielsen HJ. Høgdall CK, et al. Among authors: stephens rw. APMIS. 2002 Sep;110(9):630-8. doi: 10.1034/j.1600-0463.2002.1100906.x. APMIS. 2002. PMID: 12529016

7

Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.

Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sørensen S, Danø K, Brünner N. Stephens RW, et al. J Natl Cancer Inst. 1999 May 19;91(10):869-74. doi: 10.1093/jnci/91.10.869. J Natl Cancer Inst. 1999. PMID: 10340907

8

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.

Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Høyer-Hansen G, Brünner N, Stephens RW. Holten-Andersen MN, et al. Among authors: stephens rw. Br J Cancer. 1999 May;80(3-4):495-503. doi: 10.1038/sj.bjc.6690384. Br J Cancer. 1999. PMID: 10408859 Free PMC article.

9

The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival.

Pedersen AN, Christensen IJ, Stephens RW, Briand P, Mouridsen HT, Danø K, Brünner N. Pedersen AN, et al. Among authors: stephens rw. Cancer Res. 2000 Dec 15;60(24):6927-34. Cancer Res. 2000. PMID: 11156392

10

Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients.

Pedersen AN, Brünner N, Høyer-Hansen G, Hamer P, Jarosz D, Larsen B, Nielsen HJ, Stephens RW. Pedersen AN, et al. Among authors: stephens rw. Clin Chem. 1999 Aug;45(8 Pt 1):1206-13. Clin Chem. 1999. PMID: 10430786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters